S

Saint-Louis Hospital | Infectious and Tropical Diseases Service

Research site

(Unclaimed)

Location

1 Avenue Claude VELLEFAUX, Paris, Île-de-France, France

Site insights

Top conditions

Top treatments

KRT-232

Ritonavir

Capecitabine

CTX

methotrexate

177Lu-PSMA-617

Tenofovir

Pembrolizumab

Maraviroc

Neratinib

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 36 total trials

A Phase 3, Randomized, Double-blind Study for Patients With Invasive Candidiasis Treated With IV Echinocandin Followed by Either Oral Ibrexafungerp or Oral Fluconazole (MARIO)

This is a multicenter, randomized, double-blind study of two treatment regimens for invasive candidiasis included candidemia. Subjects will receive i...

Active, not recruiting

Candidemia

Candidiasis, Invasive

Drug: Fluconazole

Drug: Echinocandin

A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions

The main aim of this study is to find out how well elritercept works in lowering the need for RBC transfusions. Other aims are to learn how well elri...

Enrolling

Myelodysplastic Syndromes

Drug: Placebo

Drug: Elritercept

TL-895 and KRT-232 Study in Acute Myeloid Leukemia

This study evaluates TL-895, a potent, orally available and highly selective irreversible tyrosine kinase inhibitor combined with navtemadlin (KRT-23...

Active, not recruiting

Acute Myeloid Leukemia

Drug: TL-895

Drug: KRT-232